KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Intangibles (2016 - 2022)

Esperion Therapeutics filings provide 6 years of Intangibles readings, the most recent being $56000.0 for Q4 2022.

  • On a quarterly basis, Intangibles changed 0.0% to $56000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $56000.0, a 0.0% change, with the full-year FY2022 number at $56000.0, changed 0.0% from a year prior.
  • Intangibles hit $56000.0 in Q4 2022 for Esperion Therapeutics, roughly flat from $56000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $56000.0 in Q1 2018 to a low of $56000.0 in Q1 2018.
  • Median Intangibles over the past 5 years was $56000.0 (2018), compared with a mean of $56000.0.
  • The widest YoY moves for Intangibles: up 0.0% in 2018, down 0.0% in 2018.
  • Esperion Therapeutics' Intangibles stood at $56000.0 in 2018, then changed by 0.0% to $56000.0 in 2019, then changed by 0.0% to $56000.0 in 2020, then changed by 0.0% to $56000.0 in 2021, then changed by 0.0% to $56000.0 in 2022.
  • The last three reported values for Intangibles were $56000.0 (Q4 2022), $56000.0 (Q4 2021), and $56000.0 (Q4 2020) per Business Quant data.